- Trials with a EudraCT protocol (1,865)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (86)
1,865 result(s) found for: Reference.
Displaying page 18 of 94.
EudraCT Number: 2005-004337-18 | Sponsor Protocol Number: PSN357AB-CS02 | Start Date*: 2005-12-07 |
Sponsor Name:OSI-prosidion Ltd. | ||
Full Title: A randomised, double-blind, placebo-controlled, multiple dose, time-lagged cohort, dose-escalation trial, investigating the pharmacodynamics, safety and tolerability, and the pharmacokinetics of PS... | ||
Medical condition: Diabetes type-II | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003050-96 | Sponsor Protocol Number: 04EU/BMT06 | Start Date*: 2005-12-02 | |||||||||||
Sponsor Name:IBSA | |||||||||||||
Full Title: Multicentre, prospective, assessor-blind, in parallel groups randomised and vs reference marketed product controlled confirmatory trial of the efficacy and safety of IBSA BMV medicated plaster for ... | |||||||||||||
Medical condition: chronic plaque psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013406-13 | Sponsor Protocol Number: GBM-DC-2009 | Start Date*: 2009-10-07 |
Sponsor Name:Masaryk University | ||
Full Title: First Line Therapy of Glioblastoma Multiforme with Surgical Resection, Irradiation Therapy, Temozolomide and Additional Tumour-Lysate Pulsed Dendritic Cell Vaccination. A Feasibility Phase II Study... | ||
Medical condition: Glioblastoma Multiforme | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004307-14 | Sponsor Protocol Number: BECRO/ACT/LATANOS | Start Date*: 2021-02-12 | ||||||||||||||||
Sponsor Name:actrevo GmbH | ||||||||||||||||||
Full Title: Non-inferiority, Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic BAC-free Formulation of Latanoprost 0.05 mg/mL eye drops... | ||||||||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension Elevated IOP and paediatric glaucoma. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004429-26 | Sponsor Protocol Number: CMP0119 | Start Date*: 2020-05-08 | |||||||||||
Sponsor Name:PRZEDSIEBIORSTWO FARMACEUTYCZNE LEK-AM SPÓŁKA Z OGRANICZONA ODPOWIEDZIALNOSCIA | |||||||||||||
Full Title: A multicentre, randomized, open-label, cross-over equivalence study to compare the pharmacodynamic properties, safety, and tolerability of a new combination dry powder of fluticasone propionate and... | |||||||||||||
Medical condition: asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002012-12 | Sponsor Protocol Number: BENOS-2-L | Start Date*: 2021-12-13 |
Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH | ||
Full Title: A randomised, two-period two-stage cross-over study on the relative bioavailability of two different liquid formulations of single noscapine doses (phase I/IV, open-label) in healthy volunteers (fa... | ||
Medical condition: Healthy controls | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005490-31 | Sponsor Protocol Number: REACTbyALGO-1 | Start Date*: 2013-01-07 |
Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel | ||
Full Title: An open, single-centre, non-controlled feasibility study using a softwarealgorithm based insulin therapy to control blood glucose in type 1 diabetic patients | ||
Medical condition: Diabetes mellitus type 1 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000276-40 | Sponsor Protocol Number: 04- SAL-02/BS536 | Start Date*: 2005-04-22 |
Sponsor Name:GENERICS [UK] Ltd. | ||
Full Title: A RANDOMISED, OPEN TWO WAY CROSS-OVER STUDY TO ASSESS THE BRONCHODILATING PROPERTIES OF A NEW SALBUTAMOL-HFA 134a FORMULATION GIVEN AS CUMULATIVE DOSES AND A REFERENCE SALBUTAMOL-HFA 134a FORMULAT... | ||
Medical condition: Documented asthma for at least 6 months before screening Subjects with a FEV1 of between 50-85% of the predicted normal value for age, height and gender after withholding short acting Beta2-agonist... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004744-32 | Sponsor Protocol Number: 04-SAM-01/BS554 | Start Date*: 2006-01-25 |
Sponsor Name:Merck Generics UK Ltd. | ||
Full Title: A CUMULATIVE DOSE RESPONSE STUDY TO EVALUATE THE THERAPEUTIC EQUIVALENCE OF A NEW SALMETEROL INHALATION AEROSOL CONTAINING A REPLACEMENT HFA PROPELLANT IN A PRESSURISED METERED DOSE INHALER AND EX... | ||
Medical condition: asthma bronchiale | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001906-41 | Sponsor Protocol Number: CHUBX2019/24 | Start Date*: 2021-06-16 |
Sponsor Name:CHU DE BORDEAUX | ||
Full Title: Benefit of positons emission tomography / 68Gallium citrate tomodensitometry for artificial hip and knee chronic infection diagnosis | ||
Medical condition: joint prosthesis infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000993-27 | Sponsor Protocol Number: 2019PI115 | Start Date*: 2020-07-16 | |||||||||||
Sponsor Name:CHRU NANCY | |||||||||||||
Full Title: AGATA: Value of contrast-enhanced ultrasound in adnexal torsion | |||||||||||||
Medical condition: Adnexal torsion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000123-12 | Sponsor Protocol Number: 2020110469 | Start Date*: 2021-06-22 |
Sponsor Name:Odense University Hospital | ||
Full Title: PRISMA-PET – Primary Staging of Prostate Cancer: A Randomized Controlled Trial Comparing 18F-PSMA-1007 PET/CT to Conventional Imaging. | ||
Medical condition: Newly diagnosed prostate cancer, PET/CT scan used to stage newly diagnosed prostate cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001492-39 | Sponsor Protocol Number: DA2011 | Start Date*: 2011-08-24 |
Sponsor Name:Vl-Medi Oy, Väestöliitto | ||
Full Title: A randomized study to evaluate the predictive impact of using Cerazette progestin only pill before Nexplanon implant insertion regarding bleeding control | ||
Medical condition: This study is a pilot study to test the effect of Cerazette minipill use before Nexplanon implant insertion to predict the bleeding pattern. The total subject number of 90, divided into two arms of... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006253-41 | Sponsor Protocol Number: DC-004 | Start Date*: 2012-01-05 |
Sponsor Name:The Norwegian Radium Hospital, Oslo University Hospital | ||
Full Title: Phase I/II trial for vaccine therapy with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion in patients with metastatic malignant melanoma | ||
Medical condition: Malignant melanoma stage IV M1c or better | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004148-31 | Sponsor Protocol Number: PREDMETH_NL71782.078.19 | Start Date*: 2020-02-26 |
Sponsor Name:Erasmus Medisch Centrum Dept. of Pulmonology | ||
Full Title: The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlled trial | ||
Medical condition: pulmonary sarcoidosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000178-24 | Sponsor Protocol Number: W2021.040 | Start Date*: 2023-10-20 |
Sponsor Name: | ||
Full Title: Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial. | ||
Medical condition: patients with secondary hyperparathyroidism after Roux-en-Y gastric bypass surgery (RYGB). | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003116-37 | Sponsor Protocol Number: 2015-1 | Start Date*: 2015-10-22 |
Sponsor Name:Akershus University Hospital | ||
Full Title: Postoperative analgesia with oxycodone after caesarean section | ||
Medical condition: Women who have been operated for pregnancy with caesarean section | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004496-39 | Sponsor Protocol Number: RGX-501-102 | Start Date*: 2020-08-12 |
Sponsor Name:REGENXBIO Inc. | ||
Full Title: A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501 | ||
Medical condition: Adults with homozygous familial hypercholesterolemia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002360-14 | Sponsor Protocol Number: AK-2016-HHC1 | Start Date*: 2016-09-29 | ||||||||||||||||||||||||||
Sponsor Name:Rigshospitalet, Dapartment of of Clinical Physiology, Nuclear Medicine and PET | ||||||||||||||||||||||||||||
Full Title: Phase II trial: PET/CT for staging advanced and localized oral and oropharyngeal cancer | ||||||||||||||||||||||||||||
Medical condition: Oral squamous cell cancer (OSCC) with and with out local metastasis Oropharyngeal squamous cell cancer (OPSCC) with and with out local metastasis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003218-33 | Sponsor Protocol Number: Clopidogrel-1-CPH | Start Date*: 2008-03-10 | |||||||||||
Sponsor Name:Blood bank, Rigshospitalet, University Hospital of Copenhagen | |||||||||||||
Full Title: Antitrombotisk effekt af ADP receptor inhibitor i tillæg til Aspirin til hyperkoagulable patienter der gennemgår CABG kirurgi. | |||||||||||||
Medical condition: Patients with coronary syndrome undergoing CABG in cardiopulmonary bypass receiving postoperative treatment with aspirin alone | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
